![](/img/cover-not-exists.png)
990TiPPhase III LEAP-011 trial: First-line pembrolizumab with lenvatinib in patients with advanced urothelial carcinoma ineligible to receive platinum-based chemotherapy
Loriot, Y, Balar, A, de Wit, R, Garcia, J A, Grivas, P, Matsubara, N, Frenkl, T L, Sbar, E, Jia, X C, Fouad, T, Siefker-Radtke, A OVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.086
Date:
October, 2019
File:
PDF, 84 KB
2019